Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant

Fernández-Caballero, Mariana; Jiménez Lorenzo, Maria-Josefa; Morgades de la Fe, Mireia; Ferrà Coll, Christelle; Vives Polo, Susana; Abril Sabater, Laura; Navarro Ferrando, José-Tomás; Ribera Santasusana, Josep-Maria.
Med. clín (Ed. impr.) ; 158(10): 451-457, mayo 2022. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-204549

Documentos relacionados

  1. Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant.
  2. Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.
  3. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
  4. An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
  5. Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
  6. [Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].
  7. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic.
  8. Maintenance therapy in acute myeloid leukemia: advances and controversies.
  9. Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.
  10. Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.